Investigating the added value of sensory retraining to duloxetine on pain, sensory symptoms, nerve conduction velocity, hand dexterity and static balance in patients with chemotherapy-induced sensory peripheral neuropathy- a controlled clinical trial study

Shiraz University of Medical Sciences0 个研究点目标入组 34 人开始时间: 待定最近更新: 2024年8月26日

试验速览

暂无简介。

•Age over 40 years
•Reporting the presence of symptoms of peripheral neuropathy including pain, numbness, tingling and any abnormal sensations by the patient
•A score of at least 4 out of 10 in at least one of the symptoms of neuropathy in the numeric rating scale of pain in the hands and feet in the last week
•Completion of the chemotherapy course of patients at least 3 months and at most 9 months before the start of the study and the existence of life expectancy for at least 6 months

•The presence of other types of peripheral neuropathy before the start of chemotherapy
•The presence of any wound or swelling in the treatment area (hands and feet)
•Epilepsy or cardiac arrhythmia or the presence of a pacemaker in the patient's heart
•Suffering from diabetes, hyperthyroidism, kidney failure, hepatitis, AIDS and vitamin B12 deficiency
•Use of drugs such as Gabapentin and Pregabalin by patients during the study period

发起方